Clinical trial
Diacerin for the Treatment of Epidermolysis Bullosa Simplex
NCT02470689 is registered in ClinicalTrials.gov with Tel-Aviv Sourasky Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Diacerin for the Treatment of Epidermolysis Bullosa Simplex
- Lead sponsor
- Tel-Aviv Sourasky Medical Center
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- June 30, 2015
- Completion date
- Not reported
- Enrollment
- 50 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.